샘플 요청 목록

 카트 문의
시장보고서
상품코드
1758217

세계의 혈관내 복부대동맥류(AAA) 시장

Endovascular Abdominal Aortic Aneurysm (AAA)
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 275 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 혈관내 복부대동맥류(AAA) 시장은 2030년까지 38억 달러에 도달

2024년에 30억 달러로 추정되는 세계의 혈관내 복부대동맥류(AAA) 시장은 2024-2030년에 CAGR 4.1%로 성장하며, 2030년에는 38억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 스텐트 그라프트는 CAGR 4.7%를 기록하며, 분석 기간 종료시에는 27억 달러에 달할 것으로 예측됩니다. 합성 섬유 그래프트 부문의 성장률은 분석 기간에 CAGR 2.6%로 추정됩니다.

미국 시장은 8억 690만 달러로 추정, 중국은 CAGR 7.6%로 성장 예측

미국의 혈관내 복부대동맥류(AAA) 시장은 2024년에 8억 690만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2024-2030년의 분석 기간에 CAGR 7.6%로 추이하며, 2030년에는 7억 7,380만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.6%와 3.2%로 예측됩니다. 유럽에서는 독일이 CAGR 2.4%로 성장할 것으로 예측됩니다.

세계의 혈관내 복부대동맥류(AAA) 시장 - 주요 동향과 촉진요인 정리

AAA 치료의 전망을 재정의하는 기술적 변화란?

복부대동맥류(AAA)의 치료는 개복 수술에서 혈관내 동맥류 치료(EVAR)로 대표되는 최소 침습적 기술로 패러다임이 변화하고 있습니다. 스텐트 이식편 디자인, 카테터 전달 시스템, 영상 유도 기술의 발전으로 EVAR은 많은 고소득 의료 시스템에서 주요 치료법으로 자리 잡았으며, EVAR 기술의 핵심은 모듈형 스텐트 이식편으로, 대퇴동맥을 통해 삽입하여 동맥류 부위에 정확하게 고정하는 것입니다. 동맥류 부위에 정확하게 삽입할 수 있으며, 약해진 혈관벽을 전신 순환에서 효과적으로 제거할 수 있습니다. 경피적, 무봉합 접근 및 얇은 장비로의 전환은 수술 위험이 높은 환자를 포함하여 치료 가능한 환자 집단을 크게 확대했습니다.

차세대 EVAR 시스템은 해부학적 적응성과 장기적인 밀봉 성능에 중점을 둡니다. 레일형 및 분기형 내시술의 개발로 외과의사는 짧은 경부, 각진 경부, 장기 측분지 침범 등 기존 EVAR에 적합하지 않다고 여겨졌던 동맥류를 치료할 수 있게 되었습니다. 폴리머 기반 밀봉 링, 재배치 가능한 이식편, 통합 영상 마커와 같은 기술 혁신은 내막 누출, 이동, 접근 문제와 같은 일반적인 합병증을 해결하고 있습니다. 또한 3D 융합 영상과 로봇 보조 내비게이션 등 수술 중 영상 시스템의 출현으로 시술의 정확성을 간소화하고 조영제 및 방사선 피폭을 감소시키고 있습니다. 이러한 기술적 발전은 치료 결과를 최적화할 뿐만 아니라 전 세계 치료 가이드라인과 외과 의사들의 선호도에도 영향을 미치고 있습니다.

어떤 환자군과 위험 프로파일이 임상 수요를 주도하고 있는가?

복부대동맥류의 부담은 증가하고 있으며, 이는 세계 인구의 고령화와 흡연, 고혈압, 고지혈증과 같은 교정 가능한 위험인자의 확산에 의해 크게 영향을 받고 있으며, AAA는 65세 이상의 남성에서 가장 많이 진단되지만, 역학 연구에서 고령 여성의 발병이 점점 더 많이 인식되고 있습니다. 이에 따라 일부 선진국에서는 위험군, 특히 65세 이상 남성 흡연자를 대상으로 한 선별검사 프로그램을 도입하고 있습니다. 초음파를 이용한 스크리닝이 널리 시행되면서 무증상 동맥류를 조기에 발견할 수 있게 되었고, 파열 전에 EVAR을 선택할 수 있는 환자층이 확대되었습니다.

고령자나 만성폐쇄성폐질환(COPD), 신장기능장애, 관상동맥질환 등 합병증이 있는 환자 등 수술 위험이 높은 환자들에게 EVAR은 기존 개복수술의 대안이 될 수 있습니다. 이 때문에 3차 병원, 외래수술센터(ASC), 혈관 중재시술을 전문으로 하는 하이브리드 수술실에서 수요가 증가하고 있습니다. 또한 이식편 변성 및 동맥류 낭의 확장으로 인해 첫 번째 EVAR 시술 후 재시술이 필요한 환자가 증가함에 따라 보다 내구성이 높은 새로운 이식편 기술에 대한 이차적인 수요 채널이 형성되고 있습니다. 여성의 AAA 위험도 계층화 프로토콜에 대한 임베디드과 우발적 영상 진단을 통한 동맥류 발견도 시술의 성장에 기여하고 있지만, 해부학적 차이로 인해 보편적인 장비의 적용성에 도전이 되고 있습니다.

지역 생태계와 시장 접근성은 보급에 어떤 영향을 미치고 있는가?

북미와 서유럽은 여전히 가장 성숙한 EVAR 시장으로, 높은 시술 건수, 첨단인 병원 인프라, 유리한 상환 정책이 그 원동력이 되고 있습니다. 미국은 대형 의료기기 제조업체의 존재, 지속적인 임상시험, 숙련된 혈관외과 인력 등에 힘입어 EVAR을 선도적으로 도입해 왔습니다. 유럽에서는 독일, 영국, 네덜란드와 같은 국가들이 공공 의료 시스템에서 강력한 시술의 통합을 입증하고 있으며, EVAR은 선택적 AAA 치료의 70% 이상을 차지하고 있습니다. 이들 지역에서는 정부에서 지원하는 스크리닝 구상이 환자 발굴 및 혈관내 치료로의 의뢰를 더욱 촉진하고 있습니다.

아시아태평양은 주요 성장 프론티어 지역으로 부상하고 있으며, 특히 일본, 중국, 한국에서는 고령화와 도시화로 인해 혈관 질환 발생률이 증가하고 있습니다. 일본은 기술 도입에 있으며, 선도적인 역할을 하고 있으며, 풍부한 시술 경험과 맞춤형 펜스형 기기의 보급을 볼 수 있습니다. 중국에서는 의료 인프라의 확대와 국내 기기 제조업체의 개발로 시장의 빠른 확장이 가능했습니다. 그러나 많은 신흥 국가에서는 보험 상환의 격차와 훈련의 한계가 여전히 과제로 남아있습니다. 라틴아메리카와 중동 일부 지역에서는 도입이 더디게 진행되고 있으며, 특히 고소득 환자층을 대상으로 하는 사립병원에서 도입이 진행되고 있습니다. 장비 임대, 수술 교육 프로그램, 하이브리드 수술실 설치 지원과 같은 시장 진출 전략은 이러한 미도입 지역에서 효과적임이 입증되었습니다.

EVAR 시장의 성장을 가속하는 주요 요인은?

혈관내 복부대동맥류(AAA) 시장의 성장은 세계 기술 개발, 시술의 대중화, 환자 접근성 등 여러 요인에 의해 주도되고 있습니다. 그 중 가장 중요한 것은 전 세계 동맥류 유병률 증가이며, 이러한 추세는 인구 통계학적 고령화, 생활습관 관련 위험 요인, 검진 확대 등으로 인해 더욱 악화되고 있습니다. 무증상 동맥류가 점점 더 조기에 발견됨에 따라 선택적 EVAR은 개복수술에 대한 보다 안전하고 덜 침습적인 대안으로 선호되고 있습니다. 이러한 변화는 해부학적으로 복잡한 케이스에서도 적합성, 밀폐성, 내구성을 향상시킨 스텐트 이식 시스템의 지속적인 기술 혁신으로 지원되고 있습니다.

FDA의 차세대 기기 승인과 CE 마크의 확장으로 인해 전통적인 해부학적 부문과 틈새 해부학적 부문 모두에서 임상적 채택이 증가하고 있으며, 이는 합병증 감소와 입원율 감소, 입원율 감소와 함께 가치 기반 의료 모델의 움직임과 잘 맞아떨어지고 있습니다. 가치 기반 의료 모델로의 이동은 EVAR의 낮은 합병증 발생률, 입원 기간 단축, 수술 후 이환율 감소와 잘 맞아떨어집니다. 병원과 수술센터는 이러한 시술을 지원하기 위해 하이브리드 수술실과 통합 영상 시스템에 투자하고 있으며, 이는 혈관내 접근법의 장기적인 유용성에 대한 자신감을 보여주고 있습니다.

또한 업계 기업은 훈련과 교육에 점점 더 많은 노력을 기울이고 있으며, 수술의 전문성을 표준화하기 위해 시뮬레이션 기반 프로그램과 전 세계 외과의사 네트워크를 구축하고 있습니다. 경과 관찰을 위한 원격의료와 수술 후 모니터링을 위한 웨어러블 기기의 조합은 치료 생태계를 더욱 풍요롭게 하고 있습니다. 한편, 연구개발, 특히 생체흡수성 이식 부품 및 AI 지원 이미징 툴에 대한 투자 증가는 EVAR 기술이 여전히 활발한 진화 단계에 있음을 시사합니다. 이러한 다각적인 요인들로 인해 시술 건수와 기기 혁신이 지속적으로 확대될 것이며, 당분간 EVAR이 AAA 관리의 지배적인 치료법으로 확고한 입지를 구축할 것으로 보입니다.

부문

제품 유형(스텐트 그라프트, 합성 섬유 그래프트); 최종사용자(병원 최종사용자, 외래 수술 센터 최종사용자, 기타 최종사용자)

조사 대상 기업의 예(주목 41사)

  • Abbott Laboratories
  • Artivion Inc.
  • Bentley InnoMed GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Cordis Corporation
  • CryoLife Inc.
  • Edwards Lifesciences Corp.
  • Endologix LLC
  • Getinge AB
  • JOTEC GmbH
  • LeMaitre Vascular Inc.
  • Lifetech Scientific Corp.
  • Lombard Medical Ltd.
  • Medtronic plc
  • MicroPort Scientific Corp.
  • Terumo Corporation

AI 통합

우리는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유 SLM을 조회하는 일반적인 규범을 따르는 대신에 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등 전 세계 도메인 전문가로부터 큐레이트된 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.07.09

Global Endovascular Abdominal Aortic Aneurysm (AAA) Market to Reach US$3.8 Billion by 2030

The global market for Endovascular Abdominal Aortic Aneurysm (AAA) estimated at US$3.0 Billion in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Stent Graft, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Synthetic Fabric Graft segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$806.9 Million While China is Forecast to Grow at 7.6% CAGR

The Endovascular Abdominal Aortic Aneurysm (AAA) market in the U.S. is estimated at US$806.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$773.8 Million by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Endovascular Abdominal Aortic Aneurysm (AAA) Market - Key Trends & Drivers Summarized

What Technological Shifts Are Redefining the Treatment Landscape for AAA?

The management of abdominal aortic aneurysms (AAA) has seen a paradigm shift from open surgical repair to minimally invasive techniques, primarily led by endovascular aneurysm repair (EVAR). Technological advancements in stent graft design, catheter delivery systems, and imaging guidance have enabled EVAR to become the dominant intervention method in many high-income healthcare systems. The core of EVAR technology lies in modular stent grafts that can be introduced via femoral artery access and deployed precisely at the aneurysm site, effectively excluding the weakened vessel wall from systemic circulation. The shift toward percutaneous, suture-less access and low-profile devices has significantly expanded the treatable patient population, including those with higher surgical risk.

Next-generation EVAR systems are emphasizing anatomical adaptability and long-term sealing performance. The development of fenestrated and branched endografts has allowed surgeons to treat aneurysms that were once considered unsuitable for conventional EVAR due to short or angulated necks, or involvement of visceral branches. Innovations such as polymer-based sealing rings, repositionable grafts, and integrated imaging markers are addressing common complications like endoleaks, migration, and access issues. Additionally, the emergence of intraoperative imaging systems, including 3D fusion imaging and robotic-assisted navigation, is streamlining procedural accuracy and reducing contrast and radiation exposure. These technological strides are not only optimizing procedural outcomes but also influencing treatment guidelines and surgeon preferences globally.

Which Patient Demographics and Risk Profiles Are Driving Clinical Demand?

The burden of abdominal aortic aneurysms is rising, largely influenced by the aging global population and prevalence of modifiable risk factors such as smoking, hypertension, and hyperlipidemia. AAAs are most commonly diagnosed in men aged 65 and older, though incidence among older women is increasingly recognized in epidemiological studies. As a result, screening programs have been introduced in several developed countries targeting at-risk populations, particularly male smokers over the age of 65. The broader implementation of ultrasound-based screening has led to earlier detection of asymptomatic aneurysms, thus expanding the pool of patients eligible for elective EVAR procedures before rupture occurs.

In high-risk surgical populations-such as the elderly or those with comorbidities like chronic obstructive pulmonary disease (COPD), renal dysfunction, or coronary artery disease-EVAR offers a viable treatment alternative to traditional open repair. This has driven demand across tertiary hospitals, ambulatory surgical centers, and even hybrid operating rooms tailored for vascular interventions. Furthermore, the growing number of patients requiring reintervention after initial EVAR due to graft degeneration or aneurysm sac enlargement is creating a secondary demand channel for newer, more durable graft technologies. The inclusion of women in AAA risk stratification protocols and the detection of aneurysms through incidental imaging are also contributing to procedural growth, though anatomical differences still pose challenges for universal device applicability.

How Are Regional Ecosystems and Market Access Influencing Uptake?

North America and Western Europe remain the most mature markets for EVAR, driven by high procedural volumes, advanced hospital infrastructure, and favorable reimbursement policies. The U.S. has been a leading adopter of EVAR, supported by the presence of major medical device manufacturers, continuous clinical trials, and a skilled vascular surgery workforce. In the European context, countries like Germany, the UK, and the Netherlands demonstrate strong procedural integration within public health systems, with EVAR accounting for over 70% of elective AAA repairs. Government-funded screening initiatives in these regions further fuel patient identification and referral for endovascular treatment.

Asia-Pacific is emerging as a key growth frontier, particularly in Japan, China, and South Korea, where the aging population and urbanization are increasing the incidence of vascular diseases. Japan has been at the forefront in terms of technological adoption, with robust procedural experience and widespread use of custom fenestrated devices. In China, expanding healthcare infrastructure and the development of domestic device manufacturers are enabling rapid market expansion. However, reimbursement disparities and training limitations remain challenges in many emerging economies. In Latin America and parts of the Middle East, adoption is slower but growing, especially in private hospitals catering to higher-income patient segments. Market access strategies such as device leasing, surgical training programs, and hybrid OR installation support are proving effective in these underpenetrated regions.

What Are the Key Forces Powering the Growth of the EVAR Market?

The growth in the endovascular abdominal aortic aneurysm (AAA) market is driven by several factors that collectively shape technology development, procedural adoption, and patient access worldwide. Chief among them is the increasing global prevalence of AAAs, a trend exacerbated by demographic aging, lifestyle-related risk factors, and expanded screening practices. As asymptomatic aneurysms are increasingly detected at an earlier stage, elective EVAR is being prioritized as a safer, less invasive alternative to open surgery. This shift is underpinned by continued innovation in stent graft systems that offer enhanced conformability, sealing capacity, and durability, even in anatomically complex cases.

Regulatory pathways and payer structures are also accelerating growth. With FDA approvals for next-gen devices and CE marks expanding to cover advanced fenestrated and branched solutions, clinical adoption is rising in both traditional and niche anatomical segments. The movement toward value-based healthcare models is aligning well with EVAR's lower complication rates, shorter hospital stays, and reduced postoperative morbidity. Hospitals and surgical centers are investing in hybrid ORs and integrated imaging systems to support these procedures, indicating confidence in the long-term utility of endovascular approaches.

Additionally, industry players are increasingly focused on training and education, launching simulation-based programs and global surgeon networks to standardize procedural expertise. The combination of telehealth for follow-up care and wearable devices for postoperative surveillance is further enriching the treatment ecosystem. Meanwhile, increasing investments in R&D-especially into bioresorbable graft components and AI-enabled imaging tools-suggest that EVAR technology is still in a phase of active evolution. These multifactorial drivers point toward sustained expansion in both procedure volumes and device innovation, firmly establishing EVAR as the dominant modality in AAA management for the foreseeable future.

SCOPE OF STUDY:

The report analyzes the Endovascular Abdominal Aortic Aneurysm (AAA) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Stent Graft, Synthetic Fabric Graft); End-Use (Hospital End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Artivion Inc.
  • Bentley InnoMed GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Cordis Corporation
  • CryoLife Inc.
  • Edwards Lifesciences Corp.
  • Endologix LLC
  • Getinge AB
  • JOTEC GmbH
  • LeMaitre Vascular Inc.
  • Lifetech Scientific Corp.
  • Lombard Medical Ltd.
  • Medtronic plc
  • MicroPort Scientific Corp.
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Endovascular Abdominal Aortic Aneurysm (AAA) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Aortic Aneurysms Among Aging Population Drives Demand for Endovascular Repair
    • Technological Advancements in Stent Graft Designs Propel Growth in Minimally Invasive AAA Treatments
    • Expansion of Screening Programs for Aortic Aneurysms Throws Spotlight on Early Detection and Elective Repair
    • Improved Outcomes and Lower Morbidity Rates Strengthen Business Case for Endovascular Over Open Surgery
    • Integration of 3D Imaging and Navigation Technologies Enhances Precision in Stent Graft Placement
    • Development of Fenestrated and Branched Stent Grafts Expands Addressable Patient Pool With Complex Anatomy
    • Increasing Adoption of EVAR in Ambulatory Surgical Centers Spurs Procedural Volume Growth
    • Regulatory Approvals for Next-Generation Grafts Accelerate Innovation and Clinical Uptake
    • Surge in High-Risk and Comorbid Patients Strengthens Preference for Endovascular Approaches
    • Collaboration With Vascular Surgeons Fuels Device Design Improvements and Workflow Integration
    • Clinical Data Supporting Long-Term Durability of EVAR Devices Encourages Broader Adoption
    • Growing Emphasis on Post-EVAR Surveillance Supports Demand for Follow-Up Imaging Technologies
    • Hospital Investments in Hybrid Operating Rooms Drive Multidisciplinary AAA Repair Capabilities
    • Patient Awareness Campaigns and Screening Initiatives Spur Elective Procedure Rates
    • Payer Reimbursement for Minimally Invasive Aneurysm Repairs Strengthens Financial Accessibility
    • Increasing Use of Contrast-Free and Low-Radiation Imaging Expands EVAR Safety in Renal-Impaired Patients
    • Emerging Use of AI in Aneurysm Morphology Assessment Drives Personalized Device Selection
    • Global Burden of Cardiovascular Disease Supports Government-Funded AAA Screening Programs
    • Focus on Device Miniaturization and Flexibility Enhances Access in Narrow Iliac Arteries
    • Expansion of Training and Simulation Programs Improves Vascular Surgeon Expertise in EVAR Techniques
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Endovascular Abdominal Aortic Aneurysm (AAA) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stent Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Stent Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Stent Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Synthetic Fabric Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Synthetic Fabric Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Synthetic Fabric Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제